Journal Articles
- Knott JL, Liebling S, Reed-Guy L, Croteau D, Phillips RE, Desai AS, Bagley SJ. Incidence, Management, and Outcomes of Procarbazine-Associated Hypersensitivity Reactions in Patients Receiving PCV for Lower Grade Gliomas. Neuro-Oncology Practice. April 28, 2025.
- Yopes MC, Mozeika AM, Liebling S, Haslam A, Prasad V, Lebwohl B. An Analysis of 5 Years of Randomized Trials in Gastroenterology and Hepatology Reveals 52 Medical Reversals. Digestive Diseases and Sciences. August 31, 2021.
Abstracts and Posters
- Knott JL, Liebling S, Reed-Guy L, Croteau D, Phillips RE, Desai AS, Bagley SJ. Prevalence, Management, and Outcomes of Procarbazine-Associated Hypersensitivity Reactions in Patients Receiving PCV for Low-Grade Glioma. Society for Neuro-Oncology Annual Meeting; November 22, 2024; Houston, TX.
- Jimenez Loo W, Ntamatungiro M, Barron B, Catallozzi M, Swan Sein A, Bates TA, Dathatri S, Liebling S, Kingon A. Developing a Medical Education Online Curriculum and Work-Based Assessment of Teaching Skills for Senior Medical Students. AAMC Northeast Group on Educational Affairs Annual Conference; May 11, 2022.
- Jimenez Loo W, Ntamatungiro M, Barron B, Catallozzi M, Swan Sein A, Bates TA, Dathatri S, Liebling S, Kingon A. A Medical Education Online Curriculum and Work-Based Assessment of Teaching Skills for Senior Medical Students. Columbia Celebration of Teaching and Learning Symposium; March 29, 2022; New York, NY.
- Liebling S, Mayer LES, Ranzenhofer LM, Kim BH, Minkoff HM, Rosenbaum M. Longitudinal changes in measured caloric intake in children without obesity by FTO genotype. New York City Regional Obesity Forum; September 26, 2019; New York, NY.
- Liebling S. The FTO gene and longitudinal changes in measured caloric intake in children without obesity. Abstract presented at: Columbia NIH Summer Research Program Symposium; August 7, 2019; New York, NY.
Online Publications
- Glasofer DR, Pagano N, Liebling S, Attia E. PrepareED: Eating Disorders Education. Columbia Center for Eating Disorders. 2020. En español.
- Olanzapine: A Promising Drug for Anorexia Nervosa. The Feed. December 6, 2019.
Simon Liebling, MD 